25 XP   0   0   10

Harbin Pharmaceutical Group Co Ltd
Buy, Hold or Sell?

Let's analyse Harbin Pharmaceutical Group Co Ltd together

PenkeI guess you are interested in Harbin Pharmaceutical Group Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Harbin Pharmaceutical Group Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Harbin Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Harbin Pharmaceutical Group Co Ltd.

Quick analysis of Harbin Pharmaceutical Group Co Ltd (30 sec.)










What can you expect buying and holding a share of Harbin Pharmaceutical Group Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥2.15
Expected worth in 1 year
¥2.34
How sure are you?
67.5%

+ What do you gain per year?

Total Gains per Share
¥0.21
Return On Investment
7.4%

For what price can you sell your share?

Current Price per Share
¥2.83
Expected price per share
¥2.41 - ¥3.04
How sure are you?
50%

1. Valuation of Harbin Pharmaceutical Group Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥2.83

Intrinsic Value Per Share

¥0.10 - ¥22.50

Total Value Per Share

¥2.25 - ¥24.65

2. Growth of Harbin Pharmaceutical Group Co Ltd (5 min.)




Is Harbin Pharmaceutical Group Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$748.3m$645.2m$79m10.9%

How much money is Harbin Pharmaceutical Group Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money$13.6m$16m-$2.3m-17.5%
Net Profit Margin2.5%3.2%--

How much money comes from the company's main activities?

3. Financial Health of Harbin Pharmaceutical Group Co Ltd (5 min.)




What can you expect buying and holding a share of Harbin Pharmaceutical Group Co Ltd? (5 min.)

Welcome investor! Harbin Pharmaceutical Group Co Ltd's management wants to use your money to grow the business. In return you get a share of Harbin Pharmaceutical Group Co Ltd.

What can you expect buying and holding a share of Harbin Pharmaceutical Group Co Ltd?

First you should know what it really means to hold a share of Harbin Pharmaceutical Group Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Harbin Pharmaceutical Group Co Ltd is ¥2.83. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Harbin Pharmaceutical Group Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Harbin Pharmaceutical Group Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥2.15. Based on the TTM, the Book Value Change Per Share is ¥0.05 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Harbin Pharmaceutical Group Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.010.2%0.010.2%0.010.2%0.000.0%0.000.1%
Usd Book Value Change Per Share0.010.2%0.010.2%0.010.3%0.00-0.1%0.00-0.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.010.4%
Usd Total Gains Per Share0.010.3%0.010.3%0.010.3%0.00-0.1%0.010.2%
Usd Price Per Share0.46-0.46-0.42-0.48-0.74-
Price to Earnings Ratio20.16-22.71-41.19-14.55-50.15-
Price-to-Total Gains Ratio64.53-66.42-80.47-25.40--41.17-
Price to Book Ratio1.56-1.59-1.65-1.77-2.06-
Price-to-Total Gains Ratio64.53-66.42-80.47-25.40--41.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.39054
Number of shares2560
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.010.00
Usd Total Gains Per Share0.010.00
Gains per Quarter (2560 shares)18.39-4.60
Gains per Year (2560 shares)73.55-18.39
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1667646-24-28
21213513811-48-46
31920221217-72-64
42526928623-96-82
53133736028-120-100
63740443434-144-118
74347250840-168-136
84953958245-192-154
95660665651-216-172
106267473057-240-190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%14.06.00.070.0%31.07.02.077.5%73.07.06.084.9%
Book Value Change Per Share4.00.00.0100.0%11.01.00.091.7%13.07.00.065.0%24.016.00.060.0%60.026.00.069.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%73.00.013.084.9%
Total Gains per Share4.00.00.0100.0%11.01.00.091.7%13.07.00.065.0%27.013.00.067.5%66.020.00.076.7%

Fundamentals of Harbin Pharmaceutical Group Co Ltd

About Harbin Pharmaceutical Group Co Ltd

Harbin Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and trading of pharmaceuticals in China and internationally. The company offers pharmaceutical products for blood and hematopoietic, antineoplastic and immunomodulatory, respiratory, anti-inflammatory and analgesic, and chronic diseases, as well as mineral supplements, Chinese medicines, and antibiotics. It offers its products under the Harbin Pharmaceutical, Sanjing, Gaizhonggai, Hutong, and Shiyitang brands. The company is based in Harbin, China.

Fundamental data was last updated by Penke on 2024-04-17 09:27:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Harbin Pharmaceutical Group Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Harbin Pharmaceutical Group Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 2.6% means that ¥0.03 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 2.6%. The company is making a profit. +1
  • The TTM is 2.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ2.6%TTM2.5%+0.1%
TTM2.5%YOY3.2%-0.6%
TTM2.5%5Y-0.1%+2.7%
5Y-0.1%10Y1.7%-1.9%
1.1.2. Return on Assets

Shows how efficient Harbin Pharmaceutical Group Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.7% Return on Assets means that Harbin Pharmaceutical Group Co Ltd generated ¥0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.7%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.7%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM0.7%+0.0%
TTM0.7%YOY0.9%-0.2%
TTM0.7%5Y0.0%+0.7%
5Y0.0%10Y0.5%-0.4%
1.1.3. Return on Equity

Shows how efficient Harbin Pharmaceutical Group Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 2.2% Return on Equity means Harbin Pharmaceutical Group Co Ltd generated ¥0.02 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 2.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 2.2%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.2%TTM2.2%+0.1%
TTM2.2%YOY2.8%-0.6%
TTM2.2%5Y0.1%+2.0%
5Y0.1%10Y0.9%-0.8%

1.2. Operating Efficiency of Harbin Pharmaceutical Group Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Harbin Pharmaceutical Group Co Ltd is operating .

  • Measures how much profit Harbin Pharmaceutical Group Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM2.0%-2.0%
TTM2.0%YOY4.6%-2.7%
TTM2.0%5Y1.5%+0.5%
5Y1.5%10Y1.0%+0.5%
1.2.2. Operating Ratio

Measures how efficient Harbin Pharmaceutical Group Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.65 means that the operating costs are ¥1.65 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 1.650. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.689. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.650TTM1.689-0.039
TTM1.689YOY1.708-0.019
TTM1.6895Y1.737-0.048
5Y1.73710Y1.299+0.438

1.3. Liquidity of Harbin Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Harbin Pharmaceutical Group Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.26 means the company has ¥1.26 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 1.261. The company is just able to pay all its short-term debts.
  • The TTM is 1.240. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.261TTM1.240+0.021
TTM1.240YOY1.159+0.081
TTM1.2405Y1.168+0.072
5Y1.16810Y0.696+0.472
1.3.2. Quick Ratio

Measures if Harbin Pharmaceutical Group Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.54 means the company can pay off ¥0.54 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.538. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.600. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.538TTM0.600-0.063
TTM0.600YOY0.638-0.038
TTM0.6005Y0.643-0.043
5Y0.64310Y0.665-0.022

1.4. Solvency of Harbin Pharmaceutical Group Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Harbin Pharmaceutical Group Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.62 means that Harbin Pharmaceutical Group Co Ltd assets are financed with 61.6% credit (debt) and the remaining percentage (100% - 61.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 0.616. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.620. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.616TTM0.620-0.005
TTM0.620YOY0.642-0.021
TTM0.6205Y0.603+0.018
5Y0.60310Y0.530+0.072
1.4.2. Debt to Equity Ratio

Measures if Harbin Pharmaceutical Group Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 183.9% means that company has ¥1.84 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The MRQ is 1.839. The company is just able to pay all its debts with equity.
  • The TTM is 1.873. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.839TTM1.873-0.034
TTM1.873YOY2.058-0.184
TTM1.8735Y1.768+0.105
5Y1.76810Y1.336+0.432

2. Market Valuation of Harbin Pharmaceutical Group Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Harbin Pharmaceutical Group Co Ltd generates.

  • Above 15 is considered overpriced but always compare Harbin Pharmaceutical Group Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 20.16 means the investor is paying ¥20.16 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The EOD is 17.027. Based on the earnings, the company is fair priced.
  • The MRQ is 20.156. Based on the earnings, the company is fair priced.
  • The TTM is 22.715. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.027MRQ20.156-3.129
MRQ20.156TTM22.715-2.559
TTM22.715YOY41.194-18.479
TTM22.7155Y14.550+8.164
5Y14.55010Y50.154-35.604
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The EOD is 18.210. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.556. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 11.975. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD18.210MRQ21.556-3.346
MRQ21.556TTM11.975+9.581
TTM11.975YOY-55.125+67.100
TTM11.9755Y-22.443+34.418
5Y-22.44310Y-7.160-15.284
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Harbin Pharmaceutical Group Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Harbin Pharmaceutical Group Co Ltd:

  • The EOD is 1.316. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.558. Based on the equity, the company is underpriced. +1
  • The TTM is 1.588. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.316MRQ1.558-0.242
MRQ1.558TTM1.588-0.031
TTM1.588YOY1.649-0.060
TTM1.5885Y1.774-0.186
5Y1.77410Y2.055-0.281
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Harbin Pharmaceutical Group Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0480.0480%0.052-8%-0.017+136%-0.033+170%
Book Value Per Share--2.1512.081+3%1.853+16%1.960+10%2.529-15%
Current Ratio--1.2611.240+2%1.159+9%1.168+8%0.696+81%
Debt To Asset Ratio--0.6160.620-1%0.642-4%0.603+2%0.530+16%
Debt To Equity Ratio--1.8391.873-2%2.058-11%1.768+4%1.336+38%
Dividend Per Share--0.0040.004-1%0.005-20%0.004+8%0.079-95%
Eps--0.0420.039+6%0.046-10%0.004+907%0.027+53%
Free Cash Flow Per Share--0.0390.086-55%0.053-26%0.000+101%0.131-70%
Free Cash Flow To Equity Per Share--0.0390.082-53%0.070-45%0.033+18%0.136-72%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.950+5%
Intrinsic Value_10Y_max--22.499--------
Intrinsic Value_10Y_min--0.099--------
Intrinsic Value_1Y_max--0.777--------
Intrinsic Value_1Y_min--0.129--------
Intrinsic Value_3Y_max--3.461--------
Intrinsic Value_3Y_min--0.287--------
Intrinsic Value_5Y_max--7.502--------
Intrinsic Value_5Y_min--0.333--------
Market Cap7135222400.000-18%8446288000.0008337375356.600+1%7690938415.290+10%8777691554.378-4%13606645457.189-38%
Net Profit Margin--0.0260.025+4%0.032-17%-0.001+105%0.017+51%
Operating Margin---0.020-100%0.046-100%0.015-100%0.010-100%
Operating Ratio--1.6501.689-2%1.708-3%1.737-5%1.299+27%
Pb Ratio1.316-18%1.5581.588-2%1.649-6%1.774-12%2.055-24%
Pe Ratio17.027-18%20.15622.715-11%41.194-51%14.550+39%50.154-60%
Price Per Share2.830-18%3.3503.305+1%3.048+10%3.481-4%5.396-38%
Price To Free Cash Flow Ratio18.210-18%21.55611.975+80%-55.125+356%-22.443+204%-7.160+133%
Price To Total Gains Ratio54.510-18%64.52666.422-3%80.466-20%25.403+154%-41.169+164%
Quick Ratio--0.5380.600-10%0.638-16%0.643-16%0.665-19%
Return On Assets--0.0070.007+4%0.009-15%0.000+1787%0.005+61%
Return On Equity--0.0220.022+3%0.028-20%0.001+1673%0.009+142%
Total Gains Per Share--0.0520.0520%0.057-9%-0.013+125%0.046+14%
Usd Book Value--748351844.796724283143.081+3%645276743.716+16%682109296.169+10%879989967.833-15%
Usd Book Value Change Per Share--0.0070.0070%0.007-8%-0.002+136%-0.005+170%
Usd Book Value Per Share--0.2970.287+3%0.256+16%0.270+10%0.349-15%
Usd Dividend Per Share--0.0010.001-1%0.001-20%0.001+8%0.011-95%
Usd Eps--0.0060.005+6%0.006-10%0.001+907%0.004+53%
Usd Free Cash Flow--13518286.47329778174.819-55%18369443.005-26%-95591.517+101%43460595.727-69%
Usd Free Cash Flow Per Share--0.0050.012-55%0.007-26%0.000+101%0.018-70%
Usd Free Cash Flow To Equity Per Share--0.0050.011-53%0.010-45%0.005+18%0.019-72%
Usd Market Cap984660691.200-18%1165587744.0001150557799.211+1%1061349501.310+10%1211321434.504-4%1877717073.092-38%
Usd Price Per Share0.391-18%0.4620.456+1%0.421+10%0.480-4%0.745-38%
Usd Profit--14457169.25513636588.573+6%16020410.304-10%1440855.327+903%9451462.285+53%
Usd Revenue--546856233.721533251944.602+3%476402265.807+15%446294575.143+23%462312158.339+18%
Usd Total Gains Per Share--0.0070.0070%0.008-9%-0.002+125%0.006+14%
 EOD+4 -4MRQTTM+19 -16YOY+13 -225Y+26 -910Y+17 -19

3.2. Fundamental Score

Let's check the fundamental score of Harbin Pharmaceutical Group Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.027
Price to Book Ratio (EOD)Between0-11.316
Net Profit Margin (MRQ)Greater than00.026
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.538
Current Ratio (MRQ)Greater than11.261
Debt to Asset Ratio (MRQ)Less than10.616
Debt to Equity Ratio (MRQ)Less than11.839
Return on Equity (MRQ)Greater than0.150.022
Return on Assets (MRQ)Greater than0.050.007
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Harbin Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.523
Ma 20Greater thanMa 502.892
Ma 50Greater thanMa 1002.898
Ma 100Greater thanMa 2003.112
OpenGreater thanClose2.820
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets14,112,149
Total Liabilities8,689,309
Total Stockholder Equity4,724,090
 As reported
Total Liabilities 8,689,309
Total Stockholder Equity+ 4,724,090
Total Assets = 14,112,149

Assets

Total Assets14,112,149
Total Current Assets10,396,022
Long-term Assets3,716,127
Total Current Assets
Cash And Cash Equivalents 3,060,402
Net Receivables 4,432,046
Inventory 1,924,254
Other Current Assets 93,296
Total Current Assets  (as reported)10,396,022
Total Current Assets  (calculated)9,509,998
+/- 886,024
Long-term Assets
Property Plant Equipment 2,468,111
Goodwill 39,147
Intangible Assets 478,239
Long-term Assets Other 15,507
Long-term Assets  (as reported)3,716,127
Long-term Assets  (calculated)3,001,004
+/- 715,123

Liabilities & Shareholders' Equity

Total Current Liabilities8,242,982
Long-term Liabilities446,328
Total Stockholder Equity4,724,090
Total Current Liabilities
Short Long Term Debt 1,658,089
Accounts payable 3,950,622
Other Current Liabilities 124,360
Total Current Liabilities  (as reported)8,242,982
Total Current Liabilities  (calculated)5,733,071
+/- 2,509,911
Long-term Liabilities
Long term Debt 32,629
Capital Lease Obligations Min Short Term Debt31,077
Long-term Liabilities  (as reported)446,328
Long-term Liabilities  (calculated)63,706
+/- 382,622
Total Stockholder Equity
Retained Earnings 1,996,505
Total Stockholder Equity (as reported)4,724,090
Total Stockholder Equity (calculated)1,996,505
+/- 2,727,585
Other
Capital Stock2,521,279
Common Stock Shares Outstanding 2,521,279
Net Invested Capital 6,414,807
Net Working Capital 2,153,040
Property Plant and Equipment Gross 2,468,111



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-312000-06-30
> Total Assets 
4,569,481
4,449,400
4,840,675
5,766,310
5,805,744
5,932,530
6,142,714
5,953,473
6,444,929
6,366,866
6,907,538
6,578,184
6,634,992
6,796,255
7,674,652
7,492,883
8,078,138
7,825,145
8,134,964
8,630,610
9,413,098
9,154,724
9,681,779
9,395,839
8,581,368
8,921,046
9,416,831
9,449,812
8,798,761
8,797,966
9,181,411
9,683,097
10,265,060
10,383,540
10,578,872
10,007,164
10,671,522
10,853,572
11,682,594
11,762,626
12,165,502
12,537,929
11,693,027
11,659,151
15,794,524
15,323,699
15,395,731
15,667,179
15,854,142
15,687,338
15,730,131
16,455,348
16,525,577
16,195,833
15,923,890
16,243,078
16,150,166
15,716,289
15,632,885
13,766,009
13,572,956
14,289,954
14,181,360
15,052,745
14,671,681
13,444,568
13,572,919
13,699,333
13,726,314
11,903,560
11,961,636
11,900,902
11,360,161
11,201,696
11,915,560
12,502,531
12,372,198
10,794,685
11,631,739
11,847,534
11,785,991
12,041,242
12,307,963
12,842,439
12,764,204
12,958,498
13,029,769
13,435,981
13,540,957
13,734,669
13,918,035
14,112,149
14,112,14913,918,03513,734,66913,540,95713,435,98113,029,76912,958,49812,764,20412,842,43912,307,96312,041,24211,785,99111,847,53411,631,73910,794,68512,372,19812,502,53111,915,56011,201,69611,360,16111,900,90211,961,63611,903,56013,726,31413,699,33313,572,91913,444,56814,671,68115,052,74514,181,36014,289,95413,572,95613,766,00915,632,88515,716,28916,150,16616,243,07815,923,89016,195,83316,525,57716,455,34815,730,13115,687,33815,854,14215,667,17915,395,73115,323,69915,794,52411,659,15111,693,02712,537,92912,165,50211,762,62611,682,59410,853,57210,671,52210,007,16410,578,87210,383,54010,265,0609,683,0979,181,4118,797,9668,798,7619,449,8129,416,8318,921,0468,581,3689,395,8399,681,7799,154,7249,413,0988,630,6108,134,9647,825,1458,078,1387,492,8837,674,6526,796,2556,634,9926,578,1846,907,5386,366,8666,444,9295,953,4736,142,7145,932,5305,805,7445,766,3104,840,6754,449,4004,569,481
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,460,676
7,598,177
7,203,590
5,926,423
6,250,359
6,791,908
7,307,069
7,423,618
6,450,141
7,493,846
7,807,872
7,694,991
7,993,316
8,256,716
8,733,006
8,728,989
8,968,959
9,067,207
9,559,632
9,711,842
9,942,350
10,192,567
10,396,022
10,396,02210,192,5679,942,3509,711,8429,559,6329,067,2078,968,9598,728,9898,733,0068,256,7167,993,3167,694,9917,807,8727,493,8466,450,1417,423,6187,307,0696,791,9086,250,3595,926,4237,203,5907,598,1777,460,676000000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,218,207
2,267,340
2,047,810
562,947
619,159
625,318
675,504
957,872
748,118
1,242,136
897,000
775,152
1,055,710
827,704
1,592,106
1,753,711
2,121,353
1,813,205
2,433,495
2,424,717
2,593,967
2,765,642
3,060,402
3,060,4022,765,6422,593,9672,424,7172,433,4951,813,2052,121,3531,753,7111,592,106827,7041,055,710775,152897,0001,242,136748,118957,872675,504625,318619,159562,9472,047,8102,267,3402,218,207000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
1,237,870
1,299,591
1,497,851
1,097,822
1,217,118
1,231,560
1,343,509
1,176,440
1,566,776
1,301,478
1,802,638
1,403,729
1,526,949
1,653,632
2,221,338
1,618,568
2,176,137
2,012,535
2,315,797
1,784,696
2,427,600
2,237,889
2,635,261
2,202,303
1,944,484
2,073,679
2,174,002
2,026,640
1,737,328
2,635,098
2,666,426
2,414,613
2,778,214
2,717,944
2,970,134
2,532,950
2,927,853
2,714,273
3,026,936
2,793,626
3,560,297
3,769,797
3,874,921
3,531,164
5,717,618
5,160,137
5,111,434
4,873,578
5,428,763
4,507,581
5,147,872
5,641,820
6,048,190
5,148,694
4,741,190
4,446,954
5,230,090
5,042,096
4,599,003
4,068,778
3,487,480
3,366,697
3,122,627
3,501,288
3,310,890
3,485,068
3,767,199
3,610,025
3,836,245
3,749,705
3,765,868
3,273,181
2,977,357
3,094,427
3,409,278
4,376,036
4,189,698
3,838,081
4,425,425
4,737,113
4,886,566
4,945,760
5,261,692
4,834,656
4,945,467
4,897,896
5,158,332
4,996,986
5,232,726
5,231,297
4,565,240
4,432,046
4,432,0464,565,2405,231,2975,232,7264,996,9865,158,3324,897,8964,945,4674,834,6565,261,6924,945,7604,886,5664,737,1134,425,4253,838,0814,189,6984,376,0363,409,2783,094,4272,977,3573,273,1813,765,8683,749,7053,836,2453,610,0253,767,1993,485,0683,310,8903,501,2883,122,6273,366,6973,487,4804,068,7784,599,0035,042,0965,230,0904,446,9544,741,1905,148,6946,048,1905,641,8205,147,8724,507,5815,428,7634,873,5785,111,4345,160,1375,717,6183,531,1643,874,9213,769,7973,560,2972,793,6263,026,9362,714,2732,927,8532,532,9502,970,1342,717,9442,778,2142,414,6132,666,4262,635,0981,737,3282,026,6402,174,0022,073,6791,944,4842,202,3032,635,2612,237,8892,427,6001,784,6962,315,7972,012,5352,176,1371,618,5682,221,3381,653,6321,526,9491,403,7291,802,6381,301,4781,566,7761,176,4401,343,5091,231,5601,217,1181,097,8221,497,8511,299,5911,237,870
       Other Current Assets 
73,163
178,101
63,203
124,081
119,204
126,130
122,760
120,400
133,992
123,445
123,864
184,809
104,007
97,988
139,789
215,107
152,341
93,791
111,740
224,982
123,022
207,070
161,145
156,266
141,002
109,781
93,470
92,340
1,011,566
129,458
126,856
479,120
171,480
180,404
109,138
247,241
375,231
329,218
470,102
367,578
309,523
406,671
436,543
307,075
420,433
402,549
418,094
674,415
473,177
508,868
468,555
419,387
332,700
248,164
261,821
421,374
344,042
181,543
180,894
227,536
143,650
172,288
183,813
173,753
189,446
224,077
221,792
221,534
192,672
210,473
237,887
175,216
38,505
40,753
40,570
207,011
279,264
229,226
261,390
286,742
316,663
273,520
318,224
242,450
276,130
257,074
364,165
324,980
316,082
270,802
72,961
93,296
93,29672,961270,802316,082324,980364,165257,074276,130242,450318,224273,520316,663286,742261,390229,226279,264207,01140,57040,75338,505175,216237,887210,473192,672221,534221,792224,077189,446173,753183,813172,288143,650227,536180,894181,543344,042421,374261,821248,164332,700419,387468,555508,868473,177674,415418,094402,549420,433307,075436,543406,671309,523367,578470,102329,218375,231247,241109,138180,404171,480479,120126,856129,4581,011,56692,34093,470109,781141,002156,266161,145207,070123,022224,982111,74093,791152,341215,107139,78997,988104,007184,809123,864123,445133,992120,400122,760126,130119,204124,08163,203178,10173,163
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,433,738
4,951,337
5,123,652
5,195,462
4,948,579
4,344,544
4,137,893
4,039,662
4,091,000
4,047,926
4,051,247
4,109,433
4,035,215
3,989,539
3,962,563
3,876,349
3,829,115
3,792,319
3,725,468
3,716,127
3,716,1273,725,4683,792,3193,829,1153,876,3493,962,5633,989,5394,035,2154,109,4334,051,2474,047,9264,091,0004,039,6624,137,8934,344,5444,948,5795,195,4625,123,6524,951,3375,433,738000000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
1,516,352
1,613,421
1,672,245
2,077,371
2,126,397
2,152,622
2,221,334
2,368,343
2,373,502
2,404,735
2,552,053
2,717,240
2,737,873
2,820,441
2,883,727
3,117,649
3,125,162
3,204,432
3,130,652
3,527,617
3,558,410
3,634,584
3,613,665
3,701,808
2,835,159
2,795,962
2,748,211
2,743,922
2,572,042
2,644,912
2,516,298
2,647,469
2,495,895
2,604,225
2,543,443
2,688,998
2,577,956
2,730,710
2,696,278
2,920,635
2,778,439
2,918,934
2,753,256
2,985,800
4,138,401
4,541,415
4,244,652
4,543,187
4,179,221
4,659,209
4,404,290
4,935,588
4,584,083
4,799,136
4,844,584
4,898,104
4,840,342
4,769,838
4,685,499
4,604,223
4,456,619
4,396,726
4,290,059
4,175,485
4,071,321
3,971,001
3,875,233
3,723,296
3,627,986
3,540,526
3,451,671
3,373,888
3,289,859
3,200,480
3,145,142
3,060,389
2,977,745
2,913,534
2,893,345
2,783,272
2,830,961
2,794,047
2,756,801
2,834,876
2,776,311
2,731,392
2,703,478
2,641,247
2,597,836
2,545,180
2,484,102
2,468,111
2,468,1112,484,1022,545,1802,597,8362,641,2472,703,4782,731,3922,776,3112,834,8762,756,8012,794,0472,830,9612,783,2722,893,3452,913,5342,977,7453,060,3893,145,1423,200,4803,289,8593,373,8883,451,6713,540,5263,627,9863,723,2963,875,2333,971,0014,071,3214,175,4854,290,0594,396,7264,456,6194,604,2234,685,4994,769,8384,840,3424,898,1044,844,5844,799,1364,584,0834,935,5884,404,2904,659,2094,179,2214,543,1874,244,6524,541,4154,138,4012,985,8002,753,2562,918,9342,778,4392,920,6352,696,2782,730,7102,577,9562,688,9982,543,4432,604,2252,495,8952,647,4692,516,2982,644,9122,572,0422,743,9222,748,2112,795,9622,835,1593,701,8083,613,6653,634,5843,558,4103,527,6173,130,6523,204,4323,125,1623,117,6492,883,7272,820,4412,737,8732,717,2402,552,0532,404,7352,373,5022,368,3432,221,3342,152,6222,126,3972,077,3711,672,2451,613,4211,516,352
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,799
7,401
7,401
7,401
7,401
7,401
7,401
1,284
1,284
1,284
1,284
1,284
1,284
1,284
1,284
1,284
1,284
1,284
1,284
0
0
0
0
0
0
0
0
0
0
0
49,760
39,147
39,147
39,147
39,147
39,147
39,147
39,147
39,147
39,147
39,14739,14739,14739,14739,14739,14739,14739,14739,14749,760000000000001,2841,2841,2841,2841,2841,2841,2841,2841,2841,2841,2841,2847,4017,4017,4017,4017,4017,4017,7990000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32,060
31,183
344,371
1,070,958
618,487
888,944
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000888,944618,4871,070,958344,37131,18332,060000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
91,197
93,956
93,379
89,104
87,371
87,247
86,625
101,204
99,483
102,965
107,835
112,544
130,194
133,388
136,562
137,238
139,800
72,204
146,231
78,520
162,008
75,056
156,685
66,085
81,790
12,424
77,332
26,944
141,159
24,806
138,846
22,856
133,909
21,151
131,043
20,408
144,811
25,208
142,091
28,090
191,698
26,715
185,804
33,439
385,289
36,754
373,573
30,877
438,727
28,383
431,913
34,470
438,097
439,139
435,245
444,885
442,084
438,189
430,729
422,033
411,667
411,421
411,136
411,777
408,339
407,876
406,029
414,868
410,318
404,512
459,420
493,848
546,751
196,184
540,898
527,775
523,265
518,244
520,914
525,364
532,033
526,538
522,434
530,568
524,031
521,605
517,637
491,767
488,751
495,941
495,441
478,239
478,239495,441495,941488,751491,767517,637521,605524,031530,568522,434526,538532,033525,364520,914518,244523,265527,775540,898196,184546,751493,848459,420404,512410,318414,868406,029407,876408,339411,777411,136411,421411,667422,033430,729438,189442,084444,885435,245439,139438,09734,470431,91328,383438,72730,877373,57336,754385,28933,439185,80426,715191,69828,090142,09125,208144,81120,408131,04321,151133,90922,856138,84624,806141,15926,94477,33212,42481,79066,085156,68575,056162,00878,520146,23172,204139,800137,238136,562133,388130,194112,544107,835102,96599,483101,20486,62587,24787,37189,10493,37993,95691,197
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
974
974
974
974
974
974
2,894,402
974
974
974
974
974
974
974
974
974
974
974
974
15,507
15,5079749749749749749749749749749749749742,894,402974974974974974974000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
2,971,915
2,824,061
3,229,740
3,088,447
3,042,848
3,080,595
3,222,232
3,075,198
3,443,971
3,231,043
3,687,196
3,448,546
3,579,618
3,406,457
3,807,241
3,586,589
4,006,512
3,655,763
3,902,419
4,238,015
4,790,129
4,448,524
4,798,219
4,431,394
4,031,867
4,257,533
4,650,725
4,395,668
3,603,706
3,496,866
3,638,801
3,894,324
4,251,694
4,861,727
4,794,146
4,022,907
4,391,315
4,875,899
5,435,626
5,217,153
5,309,743
6,061,399
5,001,077
5,245,804
7,753,438
7,096,717
7,009,533
7,015,109
6,975,173
6,873,454
6,839,266
7,682,206
7,585,808
7,268,128
6,998,477
7,473,005
7,208,113
6,547,969
8,344,427
6,283,003
6,032,279
6,448,481
6,090,088
6,754,641
7,654,441
6,109,001
6,304,860
6,217,745
6,083,672
5,366,110
5,528,290
5,619,980
5,717,240
5,824,593
6,228,140
6,559,710
6,759,181
5,886,512
6,933,163
7,858,964
7,710,251
7,743,817
7,801,181
8,421,954
8,233,515
8,373,836
8,392,499
8,484,927
8,447,948
8,559,657
8,615,181
8,689,309
8,689,3098,615,1818,559,6578,447,9488,484,9278,392,4998,373,8368,233,5158,421,9547,801,1817,743,8177,710,2517,858,9646,933,1635,886,5126,759,1816,559,7106,228,1405,824,5935,717,2405,619,9805,528,2905,366,1106,083,6726,217,7456,304,8606,109,0017,654,4416,754,6416,090,0886,448,4816,032,2796,283,0038,344,4276,547,9697,208,1137,473,0056,998,4777,268,1287,585,8087,682,2066,839,2666,873,4546,975,1737,015,1097,009,5337,096,7177,753,4385,245,8045,001,0776,061,3995,309,7435,217,1535,435,6264,875,8994,391,3154,022,9074,794,1464,861,7274,251,6943,894,3243,638,8013,496,8663,603,7064,395,6684,650,7254,257,5334,031,8674,431,3944,798,2194,448,5244,790,1294,238,0153,902,4193,655,7634,006,5123,586,5893,807,2413,406,4573,579,6183,448,5463,687,1963,231,0433,443,9713,075,1983,222,2323,080,5953,042,8483,088,4473,229,7402,824,0612,971,915
   > Total Current Liabilities 
2,535,651
2,603,438
2,850,827
2,804,390
2,792,788
2,827,535
2,969,931
2,885,376
3,194,293
2,947,960
3,363,414
3,033,029
3,066,716
2,881,142
3,082,930
2,957,231
3,376,379
3,042,157
3,355,129
3,932,712
4,477,915
4,162,348
4,373,062
4,025,166
3,748,083
4,028,871
4,421,850
4,175,026
3,367,608
3,322,503
3,460,551
3,695,081
4,052,314
4,661,667
4,602,556
3,837,420
4,201,775
4,675,975
5,229,452
4,882,832
4,977,569
5,719,031
4,564,311
4,813,883
7,154,141
6,501,287
6,356,913
6,344,711
6,305,127
6,205,041
6,164,475
6,996,210
6,897,109
6,589,733
6,325,245
6,750,645
6,483,758
5,833,264
7,635,847
5,594,057
5,352,206
5,777,228
5,426,993
6,069,642
6,977,440
5,445,149
5,647,921
5,642,688
5,515,350
4,813,703
4,984,372
5,093,281
5,196,851
5,315,176
5,726,223
6,068,591
6,274,895
5,406,702
6,458,505
7,306,790
7,098,132
7,135,693
7,199,948
7,854,773
7,681,097
7,812,049
7,847,174
8,001,753
7,958,526
8,086,791
8,158,678
8,242,982
8,242,9828,158,6788,086,7917,958,5268,001,7537,847,1747,812,0497,681,0977,854,7737,199,9487,135,6937,098,1327,306,7906,458,5055,406,7026,274,8956,068,5915,726,2235,315,1765,196,8515,093,2814,984,3724,813,7035,515,3505,642,6885,647,9215,445,1496,977,4406,069,6425,426,9935,777,2285,352,2065,594,0577,635,8475,833,2646,483,7586,750,6456,325,2456,589,7336,897,1096,996,2106,164,4756,205,0416,305,1276,344,7116,356,9136,501,2877,154,1414,813,8834,564,3115,719,0314,977,5694,882,8325,229,4524,675,9754,201,7753,837,4204,602,5564,661,6674,052,3143,695,0813,460,5513,322,5033,367,6084,175,0264,421,8504,028,8713,748,0834,025,1664,373,0624,162,3484,477,9153,932,7123,355,1293,042,1573,376,3792,957,2313,082,9302,881,1423,066,7163,033,0293,363,4142,947,9603,194,2932,885,3762,969,9312,827,5352,792,7882,804,3902,850,8272,603,4382,535,651
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,105
100,284
101,313
214,000
289,144
319,274
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000319,274289,144214,000101,313100,284100,105000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100,105
100,284
101,313
214,000
289,144
319,274
533,717
848,911
848,909
1,265,532
1,634,084
1,617,365
1,656,420
1,539,792
2,077,703
1,881,467
2,252,856
1,992,344
1,932,960
1,861,254
1,781,727
1,803,792
1,658,089
1,658,0891,803,7921,781,7271,861,2541,932,9601,992,3442,252,8561,881,4672,077,7031,539,7921,656,4201,617,3651,634,0841,265,532848,909848,911533,717319,274289,144214,000101,313100,284100,105000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
552,299
503,802
593,596
591,476
528,802
599,885
592,341
573,462
548,984
534,386
867,614
840,030
668,542
767,163
980,187
957,707
1,176,878
991,220
1,029,320
1,416,738
1,701,688
1,459,096
1,502,831
1,677,725
1,180,037
1,511,803
1,540,608
1,591,672
1,223,921
1,669,577
1,808,248
1,912,550
2,134,938
2,339,660
2,531,272
2,647,202
2,766,365
3,094,879
3,329,327
3,389,342
3,383,003
3,279,107
3,032,909
3,442,442
4,435,185
3,890,039
3,872,194
4,035,665
4,003,728
3,982,516
3,894,002
4,749,744
4,609,322
4,296,297
4,156,369
4,431,698
4,136,461
3,810,228
3,555,580
3,368,886
3,240,565
3,516,968
3,260,037
3,786,270
3,488,018
3,251,830
3,333,852
3,368,889
3,218,203
2,709,043
2,828,606
3,132,236
3,190,855
3,264,532
3,725,810
3,722,584
3,553,351
2,802,006
3,429,722
3,667,880
3,395,062
3,412,557
3,633,321
3,482,397
3,632,890
3,471,483
3,747,180
3,509,947
3,692,163
3,979,341
3,813,951
3,950,622
3,950,6223,813,9513,979,3413,692,1633,509,9473,747,1803,471,4833,632,8903,482,3973,633,3213,412,5573,395,0623,667,8803,429,7222,802,0063,553,3513,722,5843,725,8103,264,5323,190,8553,132,2362,828,6062,709,0433,218,2033,368,8893,333,8523,251,8303,488,0183,786,2703,260,0373,516,9683,240,5653,368,8863,555,5803,810,2284,136,4614,431,6984,156,3694,296,2974,609,3224,749,7443,894,0023,982,5164,003,7284,035,6653,872,1943,890,0394,435,1853,442,4423,032,9093,279,1073,383,0033,389,3423,329,3273,094,8792,766,3652,647,2022,531,2722,339,6602,134,9381,912,5501,808,2481,669,5771,223,9211,591,6721,540,6081,511,8031,180,0371,677,7251,502,8311,459,0961,701,6881,416,7381,029,320991,2201,176,878957,707980,187767,163668,542840,030867,614534,386548,984573,462592,341599,885528,802591,476593,596503,802552,299
       Other Current Liabilities 
1,364,995
1,435,328
1,624,510
1,513,692
1,586,459
1,580,517
1,713,263
1,526,351
1,794,650
1,683,746
1,785,164
1,543,800
1,704,226
1,397,997
1,373,246
1,166,031
1,339,459
1,215,186
1,394,539
1,300,281
1,429,075
1,366,861
1,537,536
1,686,392
1,109,665
1,055,383
1,375,441
1,100,736
2,123,687
1,468,700
1,596,806
926,855
1,061,521
1,465,973
1,215,071
1,139,826
1,384,839
1,530,346
1,849,196
1,404,402
1,505,299
2,350,478
1,441,777
1,281,637
2,313,326
2,210,439
2,077,391
1,957,239
2,045,753
1,968,800
2,041,769
2,117,583
2,143,726
2,182,195
2,057,456
2,207,349
2,235,519
1,911,079
3,926,466
2,076,357
1,999,147
2,147,587
2,054,104
2,184,341
3,376,212
2,079,930
2,100,502
2,060,052
2,083,222
1,413,154
1,501,699
1,182,142
101,492
101,671
101,850
1,175,351
1,334,903
1,174,790
1,213,599
1,244,296
1,510,931
1,468,292
1,482,964
1,582,943
1,547,906
1,404,385
1,480,041
1,854,240
1,795,968
1,653,537
125,857
124,360
124,360125,8571,653,5371,795,9681,854,2401,480,0411,404,3851,547,9061,582,9431,482,9641,468,2921,510,9311,244,2961,213,5991,174,7901,334,9031,175,351101,850101,671101,4921,182,1421,501,6991,413,1542,083,2222,060,0522,100,5022,079,9303,376,2122,184,3412,054,1042,147,5871,999,1472,076,3573,926,4661,911,0792,235,5192,207,3492,057,4562,182,1952,143,7262,117,5832,041,7691,968,8002,045,7531,957,2392,077,3912,210,4392,313,3261,281,6371,441,7772,350,4781,505,2991,404,4021,849,1961,530,3461,384,8391,139,8261,215,0711,465,9731,061,521926,8551,596,8061,468,7002,123,6871,100,7361,375,4411,055,3831,109,6651,686,3921,537,5361,366,8611,429,0751,300,2811,394,5391,215,1861,339,4591,166,0311,373,2461,397,9971,704,2261,543,8001,785,1641,683,7461,794,6501,526,3511,713,2631,580,5171,586,4591,513,6921,624,5101,435,3281,364,995
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
520,390
509,417
501,917
491,119
484,286
479,810
474,658
552,174
612,119
608,123
601,234
567,182
552,418
561,787
545,325
483,174
489,422
472,866
456,503
446,328
446,328456,503472,866489,422483,174545,325561,787552,418567,182601,234608,123612,119552,174474,658479,810484,286491,119501,917509,417520,390000000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-100,105
-100,284
-101,313
-214,000
-289,144
-319,274
0
0
0
0
0
67,019
74,598
73,441
61,607
52,152
72,568
62,890
43,681
54,654
43,499
33,394
31,077
31,07733,39443,49954,65443,68162,89072,56852,15261,60773,44174,59867,01900000-319,274-289,144-214,000-101,313-100,284-100,105000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,103
41,539
2,949
2,949
2,949
2,949
2,949
2,949
2,949
2,949
2,949
7,669
7,669
7,669
7,669
0
0
0
0
0
000007,6697,6697,6697,6692,9492,9492,9492,9492,9492,9492,9492,9492,94941,53942,103000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
131,180
87,899
99,640
100,154
103,618
103,503
64,376
63,920
62,778
72,020
64,577
75,682
77,293
78,357
71,758
69,471
72,611
71,503
63,963
69,308
67,393
0
0
0067,39369,30863,96371,50372,61169,47171,75878,35777,29375,68264,57772,02062,77863,92064,376103,503103,618100,15499,64087,899131,180000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,592,701
1,614,162
1,584,785
2,645,415
2,727,172
2,817,480
2,884,193
2,813,821
2,927,679
3,062,265
3,132,733
3,038,515
2,980,739
3,311,641
3,356,539
3,383,604
3,519,281
3,623,026
3,753,224
3,854,176
3,988,689
4,093,084
4,233,839
4,336,612
4,543,759
4,655,873
4,758,193
5,046,443
5,186,933
5,298,916
5,540,296
5,785,708
6,009,869
5,517,850
5,780,167
5,980,529
6,248,800
5,945,493
6,214,166
6,510,141
6,820,038
6,439,761
6,654,978
6,375,457
7,397,666
7,554,846
7,712,778
7,956,429
8,189,435
8,138,766
8,220,256
8,149,875
8,321,107
8,343,687
8,348,929
8,238,165
8,400,224
8,613,332
6,723,151
7,052,868
7,143,545
7,431,526
7,663,976
7,852,480
6,628,411
6,929,410
6,845,635
7,051,574
7,194,543
6,144,816
6,031,160
5,865,429
5,204,225
4,922,433
5,213,182
5,456,565
5,114,937
4,411,221
4,187,068
3,479,646
3,562,390
3,782,496
3,927,244
3,847,234
3,947,950
3,986,772
4,022,368
4,331,073
4,455,333
4,516,395
4,624,291
4,724,090
4,724,0904,624,2914,516,3954,455,3334,331,0734,022,3683,986,7723,947,9503,847,2343,927,2443,782,4963,562,3903,479,6464,187,0684,411,2215,114,9375,456,5655,213,1824,922,4335,204,2255,865,4296,031,1606,144,8167,194,5437,051,5746,845,6356,929,4106,628,4117,852,4807,663,9767,431,5267,143,5457,052,8686,723,1518,613,3328,400,2248,238,1658,348,9298,343,6878,321,1078,149,8758,220,2568,138,7668,189,4357,956,4297,712,7787,554,8467,397,6666,375,4576,654,9786,439,7616,820,0386,510,1416,214,1665,945,4936,248,8005,980,5295,780,1675,517,8506,009,8695,785,7085,540,2965,298,9165,186,9335,046,4434,758,1934,655,8734,543,7594,336,6124,233,8394,093,0843,988,6893,854,1763,753,2243,623,0263,519,2813,383,6043,356,5393,311,6412,980,7393,038,5153,132,7333,062,2652,927,6792,813,8212,884,1932,817,4802,727,1722,645,4151,584,7851,614,1621,592,701
   Common Stock
450,860
450,860
450,860
530,772
575,592
530,772
636,926
636,926
636,926
636,926
955,389
955,389
955,389
955,389
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,242,005
1,614,607
1,614,607
1,614,607
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
1,917,483
2,492,728
2,492,728
2,492,728
2,541,243
2,541,243
2,541,243
2,550,438
2,550,438
2,544,953
2,544,953
2,544,953
2,544,953
2,523,392
2,523,392
2,507,019
2,507,019
2,507,019
2,507,019
2,507,019
2,506,955
2,506,955
2,517,876
2,518,376
2,518,376
2,520,387
2,523,597
2,524,514
2,525,877
2,523,809
2,524,415
0
0
002,524,4152,523,8092,525,8772,524,5142,523,5972,520,3872,518,3762,518,3762,517,8762,506,9552,506,9552,507,0192,507,0192,507,0192,507,0192,507,0192,523,3922,523,3922,544,9532,544,9532,544,9532,544,9532,550,4382,550,4382,541,2432,541,2432,541,2432,492,7282,492,7282,492,7281,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,917,4831,614,6071,614,6071,614,6071,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,0051,242,005955,389955,389955,389955,389636,926636,926636,926636,926530,772575,592530,772450,860450,860450,860
   Retained Earnings 
149,909
132,552
133,831
36,783
111,397
200,730
266,218
138,443
251,795
385,396
442,991
234,533
215,641
479,130
521,144
507,113
638,958
727,476
859,452
875,979
1,008,067
1,104,186
1,232,598
1,115,420
1,388,383
1,505,635
1,608,324
1,581,199
1,721,689
1,833,672
2,075,052
2,236,702
2,460,863
1,968,844
2,231,161
2,351,927
2,620,197
2,307,917
2,576,591
2,769,559
3,079,456
2,699,179
2,912,395
2,576,764
3,296,097
3,453,277
3,611,209
3,825,914
4,058,920
4,008,252
4,089,742
3,985,318
5,414,169
5,436,749
5,441,992
5,331,227
5,493,286
5,706,394
3,816,213
4,024,591
4,115,267
4,403,249
4,635,699
4,812,694
3,588,624
3,889,623
3,805,849
3,949,048
4,092,017
3,042,290
2,922,226
3,025,454
1,634,864
1,737,672
1,798,396
3,132,088
2,945,453
2,798,786
2,766,694
2,054,453
2,137,323
2,344,477
2,488,602
2,425,537
2,525,983
2,547,562
2,581,952
2,889,896
3,012,190
3,072,609
1,895,175
1,996,505
1,996,5051,895,1753,072,6093,012,1902,889,8962,581,9522,547,5622,525,9832,425,5372,488,6022,344,4772,137,3232,054,4532,766,6942,798,7862,945,4533,132,0881,798,3961,737,6721,634,8643,025,4542,922,2263,042,2904,092,0173,949,0483,805,8493,889,6233,588,6244,812,6944,635,6994,403,2494,115,2674,024,5913,816,2135,706,3945,493,2865,331,2275,441,9925,436,7495,414,1693,985,3184,089,7424,008,2524,058,9203,825,9143,611,2093,453,2773,296,0972,576,7642,912,3952,699,1793,079,4562,769,5592,576,5912,307,9172,620,1972,351,9272,231,1611,968,8442,460,8632,236,7022,075,0521,833,6721,721,6891,581,1991,608,3241,505,6351,388,3831,115,4201,232,5981,104,1861,008,067875,979859,452727,476638,958507,113521,144479,130215,641234,533442,991385,396251,795138,443266,218200,730111,39736,783133,831132,552149,909
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000-214,552-214,552-214,552-238,467-238,467-211,525-211,525-211,525000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 00-1,761,575-1,759,126-1,760,286-1,759,226-1,757,652-1,756,310-1,756,580-1,746,415-1,746,359-1,744,458-1,744,332-1,741,882-1,557,090-1,000,041-845,048-1,040,482-1,270,507-885,907-330,06900000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue15,456,578
Cost of Revenue-11,404,770
Gross Profit4,051,8084,051,808
 
Operating Income (+$)
Gross Profit4,051,808
Operating Expense-14,696,327
Operating Income760,251-10,644,519
 
Operating Expense (+$)
Research Development106,015
Selling General Administrative2,489,581
Selling And Marketing Expenses0
Operating Expense14,696,3272,595,596
 
Net Interest Income (+$)
Interest Income47,097
Interest Expense-56,468
Other Finance Cost-12,976
Net Interest Income-22,348
 
Pretax Income (+$)
Operating Income760,251
Net Interest Income-22,348
Other Non-Operating Income Expenses0
Income Before Tax (EBT)650,540760,251
EBIT - interestExpense = -56,468
395,263
451,732
Interest Expense56,468
Earnings Before Interest and Taxes (EBIT)0707,008
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax650,540
Tax Provision-176,322
Net Income From Continuing Ops474,218474,218
Net Income395,263
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net022,348
 

Technical Analysis of Harbin Pharmaceutical Group Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Harbin Pharmaceutical Group Co Ltd. The general trend of Harbin Pharmaceutical Group Co Ltd is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Harbin Pharmaceutical Group Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Harbin Pharmaceutical Group Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 2.82 < 2.87 < 3.04.

The bearish price targets are: 2.72 > 2.41.

Tweet this
Harbin Pharmaceutical Group Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Harbin Pharmaceutical Group Co Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Harbin Pharmaceutical Group Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Harbin Pharmaceutical Group Co Ltd. The current macd is -0.04165398.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Harbin Pharmaceutical Group Co Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Harbin Pharmaceutical Group Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Harbin Pharmaceutical Group Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Harbin Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHarbin Pharmaceutical Group Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Harbin Pharmaceutical Group Co Ltd. The current adx is 23.24.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Harbin Pharmaceutical Group Co Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Harbin Pharmaceutical Group Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Harbin Pharmaceutical Group Co Ltd. The current sar is 2.88251848.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Harbin Pharmaceutical Group Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Harbin Pharmaceutical Group Co Ltd. The current rsi is 44.52. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Harbin Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) ChartHarbin Pharmaceutical Group Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Harbin Pharmaceutical Group Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Harbin Pharmaceutical Group Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Harbin Pharmaceutical Group Co Ltd Daily Stochastic Oscillator ChartHarbin Pharmaceutical Group Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Harbin Pharmaceutical Group Co Ltd. The current cci is -52.9209622.

Harbin Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) ChartHarbin Pharmaceutical Group Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Harbin Pharmaceutical Group Co Ltd. The current cmo is -10.04650447.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Harbin Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) ChartHarbin Pharmaceutical Group Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Harbin Pharmaceutical Group Co Ltd. The current willr is -65.625.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Harbin Pharmaceutical Group Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Harbin Pharmaceutical Group Co Ltd Daily Williams %R ChartHarbin Pharmaceutical Group Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Harbin Pharmaceutical Group Co Ltd.

Harbin Pharmaceutical Group Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Harbin Pharmaceutical Group Co Ltd. The current atr is 0.07367757.

Harbin Pharmaceutical Group Co Ltd Daily Average True Range (ATR) ChartHarbin Pharmaceutical Group Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Harbin Pharmaceutical Group Co Ltd. The current obv is 1,042,099,525.

Harbin Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) ChartHarbin Pharmaceutical Group Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Harbin Pharmaceutical Group Co Ltd. The current mfi is 33.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Harbin Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) ChartHarbin Pharmaceutical Group Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Harbin Pharmaceutical Group Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Harbin Pharmaceutical Group Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Harbin Pharmaceutical Group Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.523
Ma 20Greater thanMa 502.892
Ma 50Greater thanMa 1002.898
Ma 100Greater thanMa 2003.112
OpenGreater thanClose2.820
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Harbin Pharmaceutical Group Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Harbin Pharmaceutical Group Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Harbin Pharmaceutical Group Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Harbin Pharmaceutical Group Co Ltd

I send you an email if I find something interesting about Harbin Pharmaceutical Group Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Harbin Pharmaceutical Group Co Ltd.

Receive notifications about Harbin Pharmaceutical Group Co Ltd in your mailbox!